Blood pharmacokinetic sample collection, processing and transport in COVID-19 clinical trials
While a trial protocol will describe which drug concentration (or pharmacokinetic, PK) samples are to be collected and when, and how such samples will be prepared for analysis, it is important that site staff understand the rationale and best practice for PK sampling to help ensure robust results. This is particularly important for intensive PK sampling schedules.
The purpose of this Toolkit is to provide step-by-step guidance for taking blood PK samples from the phlebotomist to processing in an interim processing (e.g. ward) laboratory and onto an analytical laboratory in clinical trials.
We are always keen to hear from researchers and teams who have used these resources, and perhaps adapted and modified them further! Please do share your experiences or refined tools with us at: info@theglobalhealthnetwork.org
https://media.tghn.org/medialibrary/2022/01/Blood_PK_full.pdf
|
|
Start: About this toolkit --> |